30 Minutes to Relief? Real-World Data Say Yes - Top_Thought_Leaders - MDSpire

30 Minutes to Relief? Real-World Data Say Yes

Real-world patient-reported outcomes show high responder rates, favorable tolerability, and consistent satisfaction with hyoscine butylbromide plus for menstrual pain self-treatment.

  • By

  • Kathryn Wighton

  • January 9, 2026

  • 3 min

Share

Top Thought Leaders in Pathology

Brief introduction explaining scope and methodology.

Original Source(s)

30 Minutes to Relief? Real-World Data Say Yes

  • by Kathryn Wighton

  • January 9, 2026

Related Content

Women’s Engagement With Different Internet-Enabled Technologies to Access Digital Menopause Information: Mixed Methods, Multiphase Sequential Study

31 Live Births Reported Following Uterus Transplant

Single-center series details maternal, obstetric, and neonatal outcomes among recipients with uterine-factor infertility

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.